FREE Daily Stock Alerts From Stock-PR.com
Power3 Medical Products, Inc. (OTC:PWRM)
“In preparation for commercialization, our objective at this meeting was to show how Power3 ’s protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer’s disease,” stated Dr. Ira L. Goldknopf, PWRM ’s President & Chief Scientific Officer. “It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3’s protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs.”
“We are pleased that our blood tests specifically diagnose Alzheimer’s in patients, both pre- and post-treatment,” commented Helen R. Park, MS, CEO of PWRM, “and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii.”
“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.
PWRM, a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. PWRM’s products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease. PWRM ’s products analyze proteins and their mutations to assess an individual’s risk for developing disease later in life or a patient’s likelihood of responding to a particular drug; assess a patient’s risk of disease progression and disease recurrence; and measure a patient’s exposure to drug therapy. PWRM was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. PWRM was founded in 1992 and is based in The Woodlands, Texas.
To learn more about PWRM visit: http://www.Power3Medical.com
Alliant Techsystems Inc. (NYSE:ATK)
ATK was awarded today a $71 million contract by the Department of Defense to provide LUU-2D/B and LUU-19B/B illuminating flares supporting the military efforts of the United States and its allies.
The contract includes production and delivery of the flares for three years, with the first deliveries in 2011. The primary end user will be the U.S. Air Force. The LUU flares are aircraft-deployed and provide illumination for battlefield operations, search and rescue, ground targeting, and other missions. The LUU-2D/B provides visible light illumination, while the LUU-19B/B provides infrared energy.
Alliant Techsystems Inc. is a premier aerospace and defense company with operations in 24 states, Puerto Rico and internationally, and revenues of approximately $4.8 billion.
Allied Healthcare International Inc. (NASDAQ:AHCI)
AHCI, a leading provider of flexible healthcare staffing services in the United Kingdom, announced that Sandy Young, AHCI's Chief Executive Officer, will be presenting at the Oppenheimer 21st Annual Healthcare Conference to be held on November 2-3, 2010 at the Waldorf=Astoria in New York City.
AHCI's presentation is scheduled for Wednesday, November 3, at 4:30 p.m. Eastern Time.
Allied Healthcare International Inc. is a leading provider of flexible healthcare staffing services in the United Kingdom. AHCI operates a community-based network of approximately 115 branches with the capacity to provide carers (known as home health aides in the U.S.), nurses, and specialized medical personnel to locations covering approximately 90% of the U.K. population. AHCI meets the needs of private patients, community care, nursing and care homes, and hospitals.
Allied Irish Banks, p.l.c. (NYSE:AIB)
AIB announces that Group Managing Director, Mr. Colm Doherty, has formally stepped down today from the Board. This follows the announcement dated 30(th) September which stated that Mr. Doherty will depart AIB before the end of 2010.
Allied Irish Banks, p.l.c., together with its subsidiaries, provides retail and corporate banking, investment banking, and asset management services in the Republic of Ireland and internationally. AIB provides financial planning and custody services; and mutual funds, and leasing and factoring products. AIB was founded in 1825 and is headquartered in Dublin, the Republic of Ireland.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
________________________________________Be Sure To Visit stock-pr.ning.com
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.